Literature DB >> 7727050

Drug interactions with antacids. Mechanisms and clinical significance.

D C Sadowski1.   

Abstract

Concomitant use of antacid preparations with other medications is common. The potential for antacid-drug interactions is dependent upon the chemistry and physical properties of the antacid preparation. The intragastric release of free aluminum and magnesium ions has potent effects on gastrointestinal function and on drug pharmacokinetics. Antacid-drug interactions may occur secondary to changes in gastrointestinal motility or alterations in gastric and urinary pH. Direct adsorption also results in decreased drug bioavailability. Human drug interaction studies are usually performed with healthy volunteers; extrapolation of these results to clinical situations may not always be valid. However, the current literature would suggest that significant interactions with antacids do occur with certain members of the quinolone, nonsteroidal anti-inflammatory drug (NSAID) and cephalosporin classes of drugs. Notable interactions also occur with tetracycline, quinidine, ketoconazole and oral glucocorticoids. These interactions are particularly relevant in the patient with sepsis, cardiac disease or inflammatory syndromes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7727050     DOI: 10.2165/00002018-199411060-00002

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  82 in total

1.  Effects of antacids and dialysate dwell times on multiple-dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis.

Authors:  T A Golper; A I Hartstein; V H Morthland; J M Christensen
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

2.  Effect of food and various antacids on the absorption of tenoxicam.

Authors:  R O Day; S Lam; P Paull; D Wade
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

3.  The effect of food and antacid on the absorption of fendosal.

Authors:  R J Wills; R B Velagapudi; S K Puri; G J Yakatan
Journal:  Biopharm Drug Dispos       Date:  1985 Jan-Mar       Impact factor: 1.627

4.  Ciprofloxacin and antacids.

Authors:  L C Preheim; T A Cuevas; J S Roccaforte; M A Mellencamp; M J Bittner
Journal:  Lancet       Date:  1986-07-05       Impact factor: 79.321

5.  Antacid side-effects on bowel habits.

Authors:  M Ström
Journal:  Scand J Gastroenterol Suppl       Date:  1982

6.  Effect of Mylanta on naproxen bioavailability.

Authors:  S S Weber; A D Bankhurst; E Mroszczak; T L Ding
Journal:  Ther Drug Monit       Date:  1981       Impact factor: 3.681

7.  The noninterference of aluminum hydroxide gel with quinidine sulfate absorption: an approach to control quinidine-induced diarrhea.

Authors:  J A Romankiewicz; M Reidenberg; D Drayer; J E Franklin
Journal:  Am Heart J       Date:  1978-10       Impact factor: 4.749

8.  Effect of antacid and ascorbic acid on serum salicylate concentration.

Authors:  P D Hansten; W L Hayton
Journal:  J Clin Pharmacol       Date:  1980 May-Jun       Impact factor: 3.126

9.  The pharmacokinetics and tissue penetration of the fluoroquinolones.

Authors:  M G Bergeron
Journal:  Clin Invest Med       Date:  1989-02       Impact factor: 0.825

Review 10.  Pharmacokinetic optimisation of oral antifungal therapy.

Authors:  M Schäfer-Korting
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

View more
  11 in total

Review 1.  Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.

Authors:  D Fleisher; C Li; Y Zhou; L H Pao; A Karim
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

2.  Pharmacokinetics and gamma scintigraphy evaluation of two enteric coated formulations of didanosine in healthy volunteers.

Authors:  Bharat Damle; Ismat Ullah; Walter Doll; Gary Wiley; Catherine Knupp
Journal:  Br J Clin Pharmacol       Date:  2002-09       Impact factor: 4.335

3.  Safety of non-prescription medicines: knowledge and attitudes of Italian pharmacy customers.

Authors:  Laura Cuzzolin; Giuseppina Benoni
Journal:  Pharm World Sci       Date:  2009-11-18

4.  The effects of ketoconazole on ziprasidone pharmacokinetics--a placebo-controlled crossover study in healthy volunteers.

Authors:  J J Miceli; M Smith; L Robarge; T Morse; A Laurent
Journal:  Br J Clin Pharmacol       Date:  2000       Impact factor: 4.335

Review 5.  Drug interactions with antiviral drugs.

Authors:  A M Taburet; E Singlas
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

Review 6.  Drug interactions with irbesartan.

Authors:  M R Marino; N N Vachharajani
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

7.  pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model.

Authors:  Rong Zhou; Paul Moench; Christopher Heran; Xujin Lu; Neil Mathias; Teresa N Faria; Doris A Wall; Munir A Hussain; Ronald L Smith; Duxin Sun
Journal:  Pharm Res       Date:  2005-02       Impact factor: 4.200

8.  Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses.

Authors:  P J Tiseo; C A Perdomo; L T Friedhoff
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

9.  Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects.

Authors:  Gilbert Lefèvre; Polly Carpenter; Claire Souppart; Heinz Schmidli; Mark McClean; Daria Stypinski
Journal:  Br J Clin Pharmacol       Date:  2002-11       Impact factor: 4.335

Review 10.  Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists.

Authors:  Danièle Bentué-Ferrer; Olivier Tribut; Elisabeth Polard; Hervé Allain
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.